{
  "docId": "019de073-b144-743c-94c4-bc5a80eb44df",
  "docSlug": "9540d42c57dd536e8cb82c97bd211004",
  "documentTitle": "Dare Bioscience | Investor Presentation Deck | 50 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 8,
  "pageCount": 50,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a horizontal bar chart format to represent clinical trial stages for various assets.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-b144-743c-94c4-bc5a80eb44df/8",
  "deckHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df",
  "deckJsonHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df.json",
  "deckAnchorHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.55,
        "y": 0.335
      },
      "kind": "callout",
      "text": "Portfolio of numerous first-line and first-in-category product candidates. Due to the different indications and formulations, the development and regulatory timelines have the potential to converge. Converging timelines create the opportunity for multiple on market / revenue generating assets at one time, targeting the same provider call point.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff63cfe1-2f3d-4912-9946-8434766fc16f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.5,
        "x": 0.1,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Pipeline progress bars for various drug candidates",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4620440-d1c3-45db-934b-52ca6815d916",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.5,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Xaciato: Commercial license agreement with Organon; Ovaprene: Commercial license agreement with Bayer. Pivotal study collaboration with NICHD. ^505(b)(2) regulatory pathway anticipated.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ed31aa0-08ee-47fe-a3b3-46e5ca991d59",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.72,
        "x": 0.14,
        "y": 0.03
      },
      "kind": "title",
      "text": "Advancing Products Women Want – The Portfolio Snapshot",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "310b1360-3530-439c-b3ea-15e78ccfac2e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "75792b28-5bd6-48fc-aa28-0987ddf6be76",
      "evidence": "Horizontal bars representing project timelines across defined phases.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}